Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors.
T O
TO
Henderson
K C
KC
Oeffinger
J
J
Whitton
W
W
Leisenring
J
J
Neglia
A
A
Meadows
C
C
Crotty
D T
DT
Rubin
L
L
Diller
P
P
Inskip
S A
SA
Smith
M
M
Stovall
L S
LS
Constine
S
S
Hammond
G T
GT
Armstrong
L L
LL
Robison
P C
PC
Nathan
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002170:Canada / Q000453:epidemiology; D002648:Child; D015179:Colorectal Neoplasms / Q000453:epidemiology; D005770:Gastrointestinal Neoplasms / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D017671:Platinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D011159:Population Surveillance; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D012189:Retrospective Studies; D012307:Risk Factors; D017741:Survivors; D014481:United States / Q000453:epidemiology; D055815:Young Adult
D000970:Antineoplastic Agents; D017671:Platinum Compounds; D011344:Procarbazine